These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7250904)

  • 1. Effect of bestatin and muramyl-dipeptide on macrophage-bound aminopeptidase.
    Wachsmuth ED; Wüst B
    Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):563-8. PubMed ID: 7250904
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis.
    Fidler IJ; Poste G
    Prog Clin Biol Res; 1981; 75B():257-67. PubMed ID: 7323097
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of isoprinosine, levamisole, muramyl dipeptide, and SM1213 on lymphocyte and macrophage function in vitro.
    Hadden JW
    Cancer Treat Rep; 1978 Nov; 62(11):1981-5. PubMed ID: 83192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.
    Fidler IJ
    J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201
    [No Abstract]   [Full Text] [Related]  

  • 5. Muramyl dipeptide stimulation of particle clearance in several animal species.
    Waters RV; Ferraresi RW
    J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of superoxide anion and enhanced candidacidal activity as a manifestation of macrophage activation: studies with muramyl dipeptide.
    Cummings NP; Pabst MJ; Johnston RB
    Adv Exp Med Biol; 1982; 141():179-87. PubMed ID: 6283823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Macrophage activation by a synthetic constituent of mycobacterial wax D (proceedings)].
    Tanaka A; Nagao S
    Bull Int Union Tuberc; 1979 Jun; 54(2):183. PubMed ID: 526655
    [No Abstract]   [Full Text] [Related]  

  • 8. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
    Schorlemmer HU; Bosslet K; Sedlacek HH
    Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
    Leclerc C; Juy D; Bourgeois E; Chedid L
    Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
    Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
    Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
    Taniyama T; Holden HT
    Cell Immunol; 1979 Dec; 48(2):369-74. PubMed ID: 228871
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

  • 14. Macrophage activation by muramyl dipeptide (MDP) without lymphocyte participation.
    Nagao S; Miki T; Tanaka A
    Microbiol Immunol; 1981; 25(1):41-50. PubMed ID: 7253958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.
    Tanaka A; Nagao S; Imai K; Mori R
    Microbiol Immunol; 1980; 24(6):547-57. PubMed ID: 7412595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different enzymatic oscillations in vivo caused by the stereoisomers of an aminopeptidase inhibitor, bestatin.
    Aoyagi T; Wada T; Yamamoto K; Kojima F; Nagai M; Harada S; Umezawa H
    J Appl Biochem; 1984 Aug; 6(4):212-21. PubMed ID: 6520072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the mitogenicity of muramyl dipeptide.
    Wood DD; Staruch MJ
    Int J Immunopharmacol; 1981; 3(1):31-44. PubMed ID: 6975247
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
    Sone S; Fidler IJ
    J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activation of tumoricidal properties in rat alveolar macrophages by synthetic muramyl dipeptide encapsulated in liposomes.
    Sone S; Fidler IJ
    Cell Immunol; 1981 Jan; 57(1):42-50. PubMed ID: 7214534
    [No Abstract]   [Full Text] [Related]  

  • 20. Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages.
    Lkhagvaa B; Tani K; Sato K; Toyoda Y; Suzuka C; Sone S
    Cytokine; 2008 Dec; 44(3):386-91. PubMed ID: 19036603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.